Gold bars to be exempt from tariffs, White House clarifies
DUBLIN - BlackRock (NYSE:BLK), Inc. has disclosed a 1.64% stake in Mural Oncology plc, according to a regulatory filing released Thursday.
The investment management firm reported owning 283,413 ordinary shares in Mural Oncology, representing approximately 1.64% of the company. BlackRock also holds a small position in cash-settled derivatives amounting to 15 shares.
The disclosure was made in accordance with Rule 8.3 of the Irish Takeover Panel Act, which requires persons with interests in relevant securities representing 1% or more to disclose their positions.
The filing indicates that BlackRock returned 41,800 shares that were previously on loan, as reported in the dealing section of the disclosure.
The position was held as of June 11, 2025, according to the Form 8.3 submitted to the Irish Takeover Panel.
The disclosure comes amid potential takeover activity involving Mural Oncology, though no specific details about any offers were included in the regulatory filing.
This information is based on a regulatory disclosure statement filed with the Irish Takeover Panel and distributed through the Regulatory News Service of the London Stock Exchange (LON:LSEG).
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.